ARK Genomic Revolution ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARKG and other ETFs, options, and stocks.

About ARKG

ARKG is an actively managed fund that targets companies involved in the genomics industry. 

Index-Tracked
Index-Tracked
Category
Health
CategoryHealth
Number of holdings
35
Number of holdings35
Inception Date
Oct 31, 2014
Inception DateOct 31, 2014

What's in this fund

Sectors

As of December 4, 2025
Healthcare100.00%

ARKG Key Statistics

AUM
1.31B
AUM1.31B
Price-Earnings ratio
-10.10
Price-Earnings ratio-10.10
30-Day yield
30-Day yield
Average volume
2.79M
Average volume2.79M
High today
$31.87
High today$31.87
Low today
$30.79
Low today$30.79
Open price
$31.74
Open price$31.74
Volume
2.53M
Volume2.53M
52 Week high
$34.07
52 Week high$34.07
52 Week low
$17.51
52 Week low$17.51
Expense ratio
0.75
Expense ratio0.75

Stock Snapshot

The current ARK Genomic Revolution ETF(ARKG) stock price is $31.06, with a market capitalization of 1.28B. The stock trades at a price-to-earnings (P/E) ratio of -10.10 and offers a dividend yield of 3.3%.

As of 2025-12-05, ARK Genomic Revolution ETF(ARKG) stock has fluctuated between $30.79 and $31.87. The current price stands at $31.06, placing the stock +0.9% above today's low and -2.5% off the high.

ARK Genomic Revolution ETF(ARKG) shares are trading with a volume of 2.53M, against a daily average of 2.79M.

During the past year, ARK Genomic Revolution ETF(ARKG) stock moved between $17.51 at its lowest and $34.07 at its peak.

During the past year, ARK Genomic Revolution ETF(ARKG) stock moved between $17.51 at its lowest and $34.07 at its peak.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.